Collecting data on bone and soft tissue tumors
Single-center Real World Prospective Observational Study of Clinical Features, Treatment Patterns, and Survival of Bone and Soft Tissue Tumors
This study is collecting information from patients with bone and soft tissue tumors at Henan Cancer Hospital over the next ten years to see how their treatment and outcomes change over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6000 (estimated) |
| Ages | 6 Years to 99 Years |
| Sex | All |
| Sponsor | Henan Cancer Hospital Government |
| Locations | 1 site (Zhengzhou, Henan) |
| Trial ID | NCT05468970 on ClinicalTrials.gov |
What this trial studies
This observational study aims to prospectively gather and analyze real-world clinical data from patients with bone and soft tissue tumors treated at Henan Cancer Hospital over the next ten years. The focus is on evaluating changes in clinical characteristics, treatment patterns, and survival outcomes of these patients. By collecting comprehensive information on treatment methods and prognostic factors, the study seeks to provide valuable insights for future clinical treatment and research in this area.
Who should consider this trial
Good fit: Ideal candidates include patients of all ages with a confirmed pathological diagnosis of bone and soft tissue tumors who have been hospitalized at Henan Cancer Hospital.
Not a fit: Patients without a definite pathology diagnosis will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of bone and soft tissue tumors, leading to improved treatment strategies and patient outcomes.
How similar studies have performed: While this approach is observational and builds on existing knowledge, similar studies have successfully contributed to understanding treatment patterns and outcomes in oncology.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: All ages, male and female. The pathological diagnosis of BSTS in our hospital was a subtype. Has received at least one hospitalization in this hospital. The target lesions could be evaluated according to the efficacy evaluation criteria of solid tumor (RECIST; Version 1.1) Measure diameter changes. Exclusion Criteria: No definite pathology.
Where this trial is running
Zhengzhou, Henan
- Department of Bone and Soft Tissue ,Henan Cancer Hospital — Zhengzhou, Henan, China (Recruiting)
Study contacts
- Study coordinator: Wang Jiaqiang, Dr.
- Email: wjqwtj@126.com
- Phone: 13592413731
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.